These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15609762)

  • 1. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
    Berger WE; Legorreta AP; Blaiss MS; Schneider EC; Luskin AT; Stempel DA; Suissa S; Goodman DC; Stoloff SW; Chapman JA; Sullivan SD; Vollmer B; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):538-45. PubMed ID: 15609762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limits of the HEDIS criteria in determining asthma severity for children.
    Cabana MD; Slish KK; Nan B; Clark NM
    Pediatrics; 2004 Oct; 114(4):1049-55. PubMed ID: 15466104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
    Smith MJ; Rascati KL; McWilliams BC
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):40-6. PubMed ID: 14756463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the health plan employer data and information set for measuring and improving the quality of asthma care.
    Gelfand EW; Colice GL; Fromer L; Bunn WB; Davies TJ
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):298-305. PubMed ID: 17042134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroid use and outcomes in pregnancy.
    Schatz M; Leibman C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):234-8. PubMed ID: 16200813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the HEDIS criteria to identify children with persistent asthma and sustained high utilization.
    Fuhlbrigge AL; Carey VJ; Finkelstein JA; Lozano P; Inui TS; Weiss ST; Weiss KB
    Am J Manag Care; 2005 May; 11(5):325-30. PubMed ID: 15898221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process quality measures and asthma exacerbations in the medicaid population.
    Yong PL; Werner RM
    J Allergy Clin Immunol; 2009 Nov; 124(5):961-6. PubMed ID: 19748660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population.
    Mattke S; Martorell F; Hong SY; Sharma P; Cuellar A; Lurie N
    J Asthma; 2010 Apr; 47(3):323-9. PubMed ID: 20394518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F
    Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
    O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
    Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well do the HEDIS asthma inclusion criteria identify persistent asthma?
    Mosen DM; Macy E; Schatz M; Mendoza G; Stibolt TB; McGaw J; Goldstein J; Bellows J
    Am J Manag Care; 2005 Oct; 11(10):650-4. PubMed ID: 16232006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
    Lage MJ; Gross GN; Brewster C; Spalitto A
    Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunking asthma? When HEDIS takes the ACT.
    Lim KG; Patel AM; Naessens JM; Li JT; Volcheck GW; Wagie AE; Enders FB; Beebe TJ
    Am J Manag Care; 2008 Aug; 14(8):487-94. PubMed ID: 18690764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data.
    Stern L; Berman J; Lumry W; Katz L; Wang L; Rosenblatt L; Doyle JJ
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):402-8. PubMed ID: 17042149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between pediatric primary provider visits and acute asthma ED visits.
    Smith SR; Wakefield DB; Cloutier MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1041-7. PubMed ID: 17902163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.